Innovation Galaxy at ICCO 2025: Co-Creating Tomorrow’s Connected Oncology

Context & Audience

At ICCO 2025, HealthCare Innovation (LinkedIn) unveiled the Innovation Galaxy, an immersive collaborative experience developed with Add Value, Neapolis Pharma, and Nourane Association. It offered far more than a standard exhibition booth: clinicians, researchers, students, and founders co-created solutions for a more human, precise, and connected future in oncology, strengthening Tunisia’s position in the regional HealthTech landscape.^[1]

Why This Matters

The health sector’s digital transformation depends on cross-disciplinary collaboration. By gathering startups, healthcare experts, and innovators around interactive modules, the Innovation Galaxy fostered knowledge exchange and real-world testing, accelerating the adoption of digital health and precision oncology techniques. Such events act as levers for ecosystem growth, bridging scientific research, market needs, and clinical practice.^[1]

Event Highlights: Galaxies and Interactive Stations

The journey was designed around three conceptual “galaxies”:

• Earth – Information: Demystifying oncology innovation for all attendees.
• Mercury – Interaction: Hands-on, user-led exploration of new technologies.
• Venus – Communication: Empowering collaborative discovery, dialogue, and outreach.

Seven interactive stations guided participants through a spectrum of innovation:

• Global Innovations Map
• Startup Valley (flagship startups)
• Innovation Orbit (hands-on testing)
• Vision Wall
• Mini Quiz
• Innovation Astronaut
• On Air Live Podcast

Startup Valley: Spotlight on Innovators

Featured startups included:

• DATA2INNOV — Data intelligence for agile medical decision-making.
• OncoConnect — AI platform connecting doctors and pharma industries.
• MediGeniuss — Artificial intelligence for early cancer detection.
• ASQII – HealthTech — Digital solutions for streamlined patient journeys.

These ventures exemplify Tunisia’s growing capacity to deliver effective, scalable solutions for oncology and HealthTech.

Obstacles & Challenges

While collaboration is key, common pain points persist:

• Fragmentation in the regional adoption of digital health tools.
• Regulatory, funding, and skill gaps for scaling clinical innovations.
• Need for continuous cross-sector engagement to accelerate clinical validation and market access.^[1]

Levers for Ecosystem Growth

To maximize impact, similar initiatives should:

• Integrate mentorship, pilot validation with clinical partners, and academic engagement.
• Guide startups through rapid testing cycles using hands-on participant feedback.
• Strengthen public-private links and foster regional partnerships, especially across the EuroMed HealthTech ecosystem.^[1]

HCI Resources

• Accelerating Innovation in HealthTech
• Startup Programs
• Pharma & Medical Device Regulatory Services
• Experts Network
• Community Overview

External Citations

• OECD — Digital Health
• WHO — Global Strategy on Digital Health (2020–2025)

FAQ

Q: What is the Innovation Galaxy at ICCO 2025?
A: A unique collaborative exhibit where practitioners and innovators engage through seven themed, interactive stations, driving hands-on discovery and clinical innovation.
Q: Which startups were featured?
A: DATA2INNOV, OncoConnect, MediGeniuss, and ASQII – HealthTech, all working to modernize oncology and healthcare processes.
Q: Why are interactive events important for digital health?
A: They accelerate validation, facilitate stakeholder buy-in, and promote the adoption of advanced technologies in clinical care.
Q: Where can one get more support for HealthTech innovation?
A: Through HCI’s Startup Programs, Experts Network, and Regulatory Services.By HealthCare Innovation HCI Editorial Team HCI is Tunisia’s HealthTech cluster connecting startups, clinicians, and partners across the EuroMed region.